ANGLE (LON:AGL)‘s stock had its “corporate” rating reiterated by stock analysts at FinnCap in a report released on Monday. They presently have a GBX 108 ($1.46) target price on the stock. FinnCap’s price objective indicates a potential upside of 105.71% from the company’s previous close.

Shares of ANGLE (LON AGL) opened at GBX 52.50 ($0.71) on Monday. ANGLE has a one year low of GBX 32.27 ($0.44) and a one year high of GBX 80 ($1.08). The stock has a market cap of $46.54 and a PE ratio of -583.33.

ILLEGAL ACTIVITY NOTICE: This report was first posted by Watch List News and is owned by of Watch List News. If you are accessing this report on another website, it was stolen and reposted in violation of U.S. and international trademark & copyright legislation. The legal version of this report can be accessed at

ANGLE Company Profile

ANGLE plc is a holding company. The Company’s principal activity is undertaken in relation to the commercialization of its Parsortix cell separation system, with deployment in non-invasive cancer diagnostics. The Company is a specialist medical diagnostic company, which offers products for cancer diagnostics and fetal health.

Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with's FREE daily email newsletter.